tradearcher

(D) A bit early to consider long, esp. with earnings near.

NASDAQ:BLUE   bluebird bio, Inc.
Slope of ema50 is nearly flat and ema200 is mildly bearish, meaning price action at a possible inflection point near earnings. Will see $55 if bullish momentum continues. Otherwise retesting March lows for support is within it's ATR. Obey your rules.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。